Abivax

News
Card image cap

Abivax sets its course on colitis and Crohn’s

French biotech moves on with the late stage drug development, after publishing impressive clinical trial results of ABX464 for treatment of colitis and hinting its potential in Crohn’s dise

News
Card image cap

Study indicates potential breakthrough HIV drug

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.